Cargando…

Emergence of an unrelated highly aberrant clone in an AML patient at relapse four months after peripheral blood stem cell transplantation

We report a case of AML-M1 with 5q aberration at diagnosis. The patient was treated with high-dose chemotherapy (HDCT). After remission induction, he received allogenic peripheral blood stem cell transplantation (PBSCT) from an HLA-match donor brother. The successive follow-up conventional cytogenet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadam, Pratibha S., Jain, Hemani V., Parikh, Purvish M., Saikia, Tapan K., Agarwal, Sandhya, Ambulkar, Indu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2007
Materias:	Short Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168137/ https://www.ncbi.nlm.nih.gov/pubmed/21957359 http://dx.doi.org/10.4103/0971-6866.38986

Ejemplares similares

Aberrant splicing and drug resistance in AML
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2016)

Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up
por: Prakash, Balendu, et al.
Publicado: (2010)

Bilateral Conjunctival Infiltration as an Extramedullary Relapse of AML
por: Mozaheb, Zahra, et al.
Publicado: (2018)

Treatment of AML Relapse After Allo-HCT
por: Webster, Jonathan A., et al.
Publicado: (2021)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy
por: Kasahara, Kohei, et al.
Publicado: (2016)

Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML
por: Issa, Ghayas C., et al.
Publicado: (2022)

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
por: Yilmaz, Musa, et al.
Publicado: (2019)

Gene Expression Profiles Associated with Pediatric Relapsed AML
por: Bachas, Costa, et al.
Publicado: (2015)

Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma
por: Kriangkum, Jitra, et al.
Publicado: (2013)

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?
por: Webersinke, G, et al.
Publicado: (2014)

Report of chronic myeloid leukemia in chronic phase from Tata Memorial Hospital, Mumbai, 2002-2008
por: Parikh, Purvish
Publicado: (2013)

Fatty Acid Binding Protein FABP4 Mechanistically Links Obesity with Aggressive AML by Enhancing Aberrant DNA Methylation in AML Cells
por: Yan, F, et al.
Publicado: (2016)

Relapsed or primary refractory AML: moving past MEC and FLAG-ida
por: Koenig, Kristin, et al.
Publicado: (2020)

The Elephant in The Room: AML Relapse Post Allogeneic Hematopoietic Cell Transplantation
por: Abou Dalle, Iman, et al.
Publicado: (2022)

Ayurvedic Doctors Cannot Prescribe Allopathic Medicines—National Consumer Dispute Redressal Commission Judgement
por: Parikh, Purvish M.
Publicado: (2023)

Identification of Novel Genomic Aberrations in AML-M5 in a Level of Array CGH
por: Zhang, Rui, et al.
Publicado: (2014)

Identifying large sets of unrelated individuals and unrelated markers
por: Abraham, Kuruvilla Joseph, et al.
Publicado: (2014)

Chromosomal Aberrations in Couples with Pregnancy Loss: A Retrospective Study
por: Pal, Asoke K., et al.
Publicado: (2018)

Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection
por: Heidenreich, Silke, et al.
Publicado: (2017)

Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML
por: Vachhani, Pankit, et al.
Publicado: (2016)

Diffuse periostitis as the primary presenting radiological finding in an AML patient with disease relapse
por: Mushtaq, Raza, et al.
Publicado: (2018)

An agonist antibody prefers relapsed AML for induction of cells that kill each other
por: Yea, Kyungmoo, et al.
Publicado: (2019)

IDH1-mutated relapsed or refractory AML: current challenges and future prospects
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2019)

Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy
por: Nassereddine, Samah, et al.
Publicado: (2018)

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation
por: Battipaglia, Giorgia, et al.
Publicado: (2022)

Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
por: Klement, Piroska, et al.
Publicado: (2022)

P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
por: Danylesko, Ivetta, et al.
Publicado: (2023)

Chronic myeloid leukemia in the Imatinib era – Compilation of Indian data from 22 centers involving 8115 patients
por: Parikh, Purvish, et al.
Publicado: (2013)

Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
por: Lindblad, O, et al.
Publicado: (2016)

Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks
por: Bär, Isabel, et al.
Publicado: (2020)

Statistical Power to Detect Genetic (Co)Variance of Complex Traits Using SNP Data in Unrelated Samples
por: Visscher, Peter M., et al.
Publicado: (2014)

Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci.
por: Teixeira, M. R., et al.
Publicado: (1994)

Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy
por: Prakash, Balendu
Publicado: (2011)

An intensive approach to treatment for older patients with relapsed isolated NPM1 mutated AML
por: Dukka, Srivasavi, et al.
Publicado: (2015)

Granulocytic Sarcoma of the Uterus: A Rare Presentation of Extramedullary Relapse of AML and Importance of MRI
por: Ucar, Murat, et al.
Publicado: (2014)

Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease
por: Kim, Hyojeong, et al.
Publicado: (2016)

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
por: Ramaswamy, Kavitha, et al.
Publicado: (2022)

FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML
por: Zhang, Jubin, et al.
Publicado: (2022)

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mlakca47a976ih8kqh1insenob